leadf
logo-loader
viewLexaGene Holdings Inc.

LexaGene Holdings hires contract manufacturer LaunchWorks to support MiQLab launch

LaunchWorks is an FDA registered, ISO 13485 certified, cGMP compliant group specializing in manufacturing consumables for life science firms

LexaGene Holdings Inc. -
MiQLab is a fully automated genetic analyzer designed to deliver reference-quality data at the point-of-need and can return results in about one hour

LexaGene Holdings Inc (CVE:LXG) (OTCQB:LXXGF) announced Monday another milestone in its journey to commercially launch flagship analyzer product MiQLab before the end of September - the hiring of LaunchWorks as its contract manufacturer.

LaunchWorks is an FDA registered, ISO 13485 certified, cGMP compliant group specializing in manufacturing consumables for life science firms, LexaGene said.

READ: LexaGene Holdings hires first wave of experienced sales executives ahead of MiQLab launch

It will manufacture the assay panels and buffer sets used in LexaGene’s fully automated MiQLab system.

"LaunchWorks can currently manufacture enough products to easily support our commercial launch and have the facilities to scale their production to meet any demands that we require. I am very impressed by their facilities, high caliber staff, and their ability to scale their operations to meet our needs as we grow," Dr Jack Regan, LexaGene’s CEO and founder, told investors in a statement.

MiQLab is a fully automated genetic analyzer designed to deliver reference-quality data at the point-of-need and can return results in about one hour. LexaGene says the technology can be used in multiple billion-dollar markets, including human and veterinary diagnostics as well as food safety testing.

"This is an extremely exciting time for LexaGene. Our initial hires in sales are working out exceedingly well and we are in the home stretch for manufacturing and qualification. By the end of next month, we expect to begin selling and fulfilling delivery of our first units, which will be a huge milestone for the company," added Daryl Rebeck, LexaGene’s president and co-founder.

Contact the author at [email protected]

Quick facts: LexaGene Holdings Inc.

Price: 0.82 CAD

TSX-V:LXG
Market: TSX-V
Market Cap: $93.24 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Symphony Environmental Technologies hails antiviral glove and mask results...

Symphony Environmental Technologies' (LON:SYM) Michael Laurier talks to Proactive London's Katie Pilbeam about the successful coronavirus (COVID-19) test of their antiviral gloves and masks containing the company’s d2pAM antimicrobial technology. The d2pAM glove showed a 99.99%...

3 hours, 40 minutes ago

2 min read